SCHEMBL4322802

SCHEMBL4322802

Nc1cc(CN2CCN(CCCO)CC2)ccc1/C=C/c1n[nH]c2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 4/20 0.43
FLT1 P17948 3/20 0.43
AURKB Q96GD4 8/20 0.42
AURKA O14965 6/20 0.42
PKM P14618 1/20 0.38
PDGFRB P09619 2/20 0.38
KDR P35968 2/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
CHEK1 O14757 2/20 0.37
JAK2 O60674 2/20 0.37
MAP4K4 O95819 2/20 0.37
NTRK1 P04629 2/20 0.37
FLT3 P36888 2/20 0.37
PLK4 O00444 2/20 0.37
BMPR1B O00238 1/20 0.37
STK25 O00506 1/20 0.37
CIT O14578 1/20 0.37
RIOK3 O14730 1/20 0.37
IKBKB O14920 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4322813 1.00 FGFR1 (0.43) FGFR1FLT1AURKBAURKAPKM
SCHEMBL4314489 0.94 FGFR1 (0.45) FGFR1FLT1AURKBAURKAPKM
SCHEMBL4314498 0.94 FGFR1 (0.45) FGFR1FLT1AURKBAURKAPKM
SCHEMBL4308965 0.88 FGFR1 (0.44) FGFR1FLT1AURKBAURKAPDGFRB
SCHEMBL4308960 0.88 FGFR1 (0.44) FGFR1FLT1AURKBAURKAPDGFRB
SCHEMBL27711632 0.84 FGFR1 (0.43) FGFR1FLT1AURKBAURKAPDGFRB
SCHEMBL4310121 0.83 FGFR1 (0.38) FGFR1FLT1AURKBAURKAPDGFRB
SCHEMBL4310125 0.83 FGFR1 (0.38) FGFR1FLT1AURKBAURKAPDGFRB
SCHEMBL4317093 0.82 AURKB (0.37) FGFR1FLT1AURKBAURKAPDGFRB
SCHEMBL4317084 0.82 AURKB (0.37) FGFR1FLT1AURKBAURKAPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 FGFR1 18/4885FLT1 81/4885AURKB 3438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.